Rare condition

Female infertility due to an implantation defect of genetic origin

ORPHA:400025 ↗

Search all Female infertility due to an implantation defect of genetic origin trialsAlert me when a trial opens

studies recruiting now

checking live

studies registered in total

checking live

countries with a recruiting site

checking live

recruiting study posted to date

checking live

Recruiting trials

Fetching live from ClinicalTrials.gov. This condition is not yet in our weekly snapshot; live results only.

Keep watching

Get an email when a new Female infertility due to an implantation defect of genetic origin study opens.

One email a day at most. Unsubscribe with one click.

Used only for these alerts. Privacy.

Support

Patient organisations

We do not yet list a dedicated organisation for this condition. The directories below are the best route.

NORD ↗GARD ↗Orphanet ORPHA:400025 ↗

A group of conditions, not a single diagnosis

Orphanet classifies “Female infertility due to an implantation defect of genetic origin” as a category that groups several related conditions. Trials are usually registered under the specific condition, so the figures above may undercount. Browse the conditions in this group or see the classification on Orphanet.

Treatments being studied

9 approved treatments and 9 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.

Approved: Menotropins (Gynogen hp)Approved: Urofollitropin (Bravelle)Approved: ClomipheneApproved: Choriogonadotropin Alfa (Ovidrel)Approved: Follitropin Beta (Fertavid)Approved: Follitropin Alfa (Bemfola)Approved: Lutropin Alfa (Lutropin alfa component of pergoveris)Approved: Ganirelix (Orgalutran)Approved: Clomiphene Citrate (Clomid)

Phase 3Acetylcysteine (A-cys)

Phase 3Progesterone (Crinone)

Phase 3Dydrogesterone (Duphaston)

Phase 3Gonadorelin Acetate (Gnrh)

Phase 1/2Gestodene

Phase 1/2Ethinyl Estradiol (Estinyl)

Phase 1/2Somatropin (Genotropin)

Phase 1Follitropin

+ 1 more in development

Related conditions

Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).